GM-CSF-treated mice once again had a stronger diphtheria-specific antibody production compared to the placebo group after receiving all three vaccine shots (Fig. 2c), whereas there was no difference in tetanus-specific antibodies (Fig. 2d). This evidence concerns the gene CSF2 and diphtheria.